Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-22-017835
Filing Date
2022-10-14
Accepted
2022-10-14 16:37:23
Documents
21
Period of Report
2022-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp182472_6k.htm 6-K 14915
2 EXHIBIT 99.1 dp182472_ex9901.htm EX-99.1 8706
3 EXHIBIT 99.2 dp182472_ex9902.htm EX-99.2 11035
4 EXHIBIT 99.3 dp182472_ex9903.htm EX-99.3 8275
5 EXHIBIT 99.4 dp182472_ex9904.htm EX-99.4 7971
6 GRAPHIC ex9901_001.jpg GRAPHIC 508819
7 GRAPHIC ex9902_001.jpg GRAPHIC 164229
8 GRAPHIC ex9902_002.jpg GRAPHIC 97720
9 GRAPHIC ex9902_003.jpg GRAPHIC 180448
10 GRAPHIC ex9902_004.jpg GRAPHIC 175839
11 GRAPHIC ex9902_005.jpg GRAPHIC 195078
12 GRAPHIC ex9902_006.jpg GRAPHIC 192681
13 GRAPHIC ex9902_007.jpg GRAPHIC 228175
14 GRAPHIC ex9902_008.jpg GRAPHIC 188453
15 GRAPHIC ex9903_001.jpg GRAPHIC 439513
16 GRAPHIC ex9904_001.jpg GRAPHIC 157841
17 GRAPHIC ex9904_002.jpg GRAPHIC 93686
18 GRAPHIC ex9904_003.jpg GRAPHIC 151737
19 GRAPHIC ex9904_004.jpg GRAPHIC 126820
20 GRAPHIC ex9904_005.jpg GRAPHIC 182010
21 GRAPHIC ex9904_006.jpg GRAPHIC 141700
  Complete submission text file 0000950103-22-017835.txt   4493225
Mailing Address 28 BAGGOT STREET LOWER DUBLIN L2 2D02 NX43
Business Address 28 BAGGOT STREET LOWER DUBLIN L2 2D02 NX43 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 221311703
SIC: 2834 Pharmaceutical Preparations